PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshuman influenza
MeSH D007251 - human influenza
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009976:Orthomyxoviridae infections
0 Companies
0 Drugs
Success rate
D012141:Respiratory tract infections
D007251: 
Human influenza
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmantadine Amantadine  1991-08-23   
Oseltamivir Oseltamivir  2019-02-27   
GSKZanamivir Dectova  2019-04-26   
Zanamivir Relenza  1999-07-26   
RocheOseltamivir Tamiflu  1999-10-27 $311.311 M Y2020 
Baloxavir marboxil Xofluza  2021-01-07 $46.91 M Y2020 
CiplaAmantadine Amantadine  2016-09-30   
Oseltamivir Oseltamivir  2021-08-30   
Lupin ResearchOseltamivir Oseltamivir  2018-02-20   
SandozAmantadine Amantadine  1987-02-18   
Xttrium LaboratoriesAmantadine Amantadine  1998-12-24   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
57%
13/23
Phase 2
73%
19/26
Phase 3
55%
21/38
Approved: 9Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use